{
  "ticker": "HPC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968312",
  "id": "02968312",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250710",
  "time": "1659",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250710/pdf/06lpdg62plm9b0.pdf",
  "summary": "### Summary of Substantial Holder Notice:  \n**Company:** The Hydration Pharmaceuticals Company Limited (HPC)  \n**Substantial Holder:** Regal Funds Management Pty Limited and associates  \n\n#### Material Changes:  \n- **Change in Voting Power:** Reduced from **8.13% (30,072,908 shares)** to **6.84% (29,124,128 shares)** due to dilution from issuance of **39,500,000 new shares** on **8 July 2025**.  \n- **Disposal of Shares:** Sold **948,780 ordinary shares** on **7 April 2025** for **$9,487.80** (price: ~$0.01 per share).  \n- **Current Holdings:**  \n  - **28,000,000 ordinary shares** (controlled by Regal Funds Management).  \n  - **700,000 ordinary shares** (via UBS Nominees).  \n  - **424,128 ordinary shares** (via J.P. Morgan entities).  \n\n**Note:** No material impact on capital structure or liquidity; dilution reflects typical post-capital raising adjustment.  \n\n*Omitted non-material details (associate names, addresses, boilerplate).*",
  "usage": {
    "prompt_tokens": 1315,
    "completion_tokens": 248,
    "total_tokens": 1563,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-10T07:46:39.837042"
}